8-K
filed June 2, 2026, 5:10 PM ET
ticker ALLR
CIK 0001860657
leadership
confidence high
sentiment neutral
materiality 0.40
Allarity amends CEO Thomas Jensen's management agreement; increases severance, alters pay structure
Allarity Therapeutics, Inc.
- Base compensation set at SEK 6,000,000 (80%) and US$163,043 (20%) annually; eliminates $100,000 signing bonus.
- Termination for convenience: notice period increased from 15 to 30 days; now includes 12 months of Monthly Fee as severance.
- Termination for Good Reason: now entitles consultant to Accrued Payments plus 12 months of Monthly Fee (replaces prior 9 months).
- Annual bonus capped at 60% of Monthly Fees; performance metrics carry over if not updated by March 31 each year.
- Adds Section 409A and 280G tax compliance provisions; extends non-solicitation period to 12 months post-termination.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-064278
- form_type
- 8-K
- ticker
- ALLR
- cik
- 0001860657
- company_name
- Allarity Therapeutics, Inc.
- filed_at
- 2026-06-02T21:10:31+00:00
- discovered_at
- 2026-06-02T21:12:00.331393+00:00
- generated_at
- 2026-06-02T21:12:42.703316+00:00
- sec_items
- ["5.02", "9.01"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.4
- calibrated_materiality_score
- 0.4
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-064278
- json_url
- https://secwatch.observer/filing/0001213900-26-064278.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-064278.md
- text_url
- https://secwatch.observer/filing/0001213900-26-064278.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1860657/000121390026064278/0001213900-26-064278-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1860657/000121390026064278/ea0293097-8k_allarity.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
NUE
Nucor EVP David Sumoski to retire June 13, 2026; receives $308,851/month for 24 months
NUCOR CORP
June 2, 2026, 5:11 PM ET
leadership
Items 5.02, 9.01
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
Filing page
SEC filing
DIN
Dine Brands appoints Lawrence Y. Kim as Chief Commercial Officer effective June 1, 2026
Dine Brands Global, Inc.
June 2, 2026, 5:00 PM ET
leadership
Items 5.02, 9.01
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
Filing page
SEC filing
CHRW
C.H. Robinson grants $7.5M special equity to CSO Arun Rajan; ties vesting to AI, truckload growth, EPS
C. H. ROBINSON WORLDWIDE, INC.
June 2, 2026, 4:18 PM ET
leadership
Items 5.02, 9.01
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
Filing page
SEC filing
ZION
Zions Bancorporation elects Daniel J. Ryan, retired PwC partner, to board
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
June 2, 2026, 4:02 PM ET
leadership
Items 5.02, 9.01
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
Filing page
SEC filing
ONCY
Oncolytics appoints Steve Glover to board, promotes John McAdory to COO
ONCOLYTICS BIOTECH INC
June 2, 2026, 9:02 AM ET
leadership
Items 5.02, 8.01, 9.01
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
Filing page
SEC filing
GOOD
Gladstone Commercial elects George Stelljes as director; board expands to eight
GLADSTONE COMMERCIAL CORP
June 2, 2026, 8:45 AM ET
leadership
Items 5.02, 7.01, 9.01
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
Filing page
SEC filing
GAIN
Gladstone Investment Elects George Stelljes to Board, Expands to 8 Directors
GLADSTONE INVESTMENT CORPORATION\DE
June 2, 2026, 8:45 AM ET
leadership
Items 5.02, 7.01, 9.01
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
Filing page
SEC filing
AHCO
AdaptHealth amends 8-K to disclose COO Daniel McFadden's compensation: base salary raised to $550K, plus RSU grant
AdaptHealth Corp.
June 1, 2026, 9:02 PM ET
leadership
Items 5.02, 9.01
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.